Neuromuscular Blocking Agents for ARDS: Firm Evidence for ICU Mortality but Not for Long-Term Mortality

References

1. 1.↵
   1. Pelosi P,
   2. Vargas M

   . Mechanical ventilation and intraabdominal hypertension: ‘beyond good and evil’. Crit Care 2012;16(6):187.

   OpenUrl
2. 2.↵
   1. Manganelli F,
   2. Vargas M,
   3. Iovino A,
   4. Iacovazzo C,
   5. Santoro L,
   6. Servillo G

   . Brainstem involvement and respiratory failure in COVID-19. Neurol Sci 2020;41(7):1663–1665.

   OpenUrl
3. 3.↵
   1. Torbic H,
   2. Krishnan S,
   3. Harnegie MP,
   4. Duggal A

   . Neuromuscular blocking agents for ARDS: a systematic review and meta-analysis. Respir Care 2021;66(1):120–128.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Vargas M,
   2. Servillo G

   . The end of corticosteroid in sepsis: fragile results from fragile trials. Crit Care Med 2018;46(12):e1228

   OpenUrl
5. 5.
   1. Vargas M,
   2. Servillo G

   . Liberal versus conservative oxygen therapy in critically ill patients: using the fragility index to determine robust results. Crit Care 2019;23(1):132

   OpenUrl
6. 6.↵
   1. Vargas M,
   2. Buonanno P,
   3. Iacovazzo C,
   4. Servillo G

   . Epinephrine for out of hospital cardiac arrest: a systematic review and meta-analysis of randomized controlled trials [published correction appears in Resuscitation. 2019 Dec;145:R1]. Resuscitation 2019;136:54–56.

   OpenUrl
7. 7.↵
   1. Wetterslev J,
   2. Jakobsen JC,
   3. Gluud C

   . Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 2017;17(1):39.

   OpenUrlCrossRefPubMed